Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2022 | 2 |
2023 | 2 |
2024 | 0 |
Search Results
3 results
Results by year
Filters applied: . Clear all
Page 1
IFNα and 5-Aza-2'-deoxycytidine combined with a dendritic-cell targeting DNA vaccine alter tumor immune cell infiltration in the B16F10 melanoma model.
Front Immunol. 2023 Jan 19;13:1074644. doi: 10.3389/fimmu.2022.1074644. eCollection 2022.
Front Immunol. 2023.
PMID: 36741387
Free PMC article.
An intranasal stringent response vaccine targeting dendritic cells as a novel adjunctive therapy against tuberculosis.
Karanika S, Gordy JT, Neupane P, Karantanos T, Ruelas Castillo J, Quijada D, Comstock K, Sandhu AK, Kapoor AR, Hui Y, Ayeh SK, Tasneen R, Krug S, Danchik C, Wang T, Schill C, Markham RB, Karakousis PC.
Karanika S, et al.
Front Immunol. 2022 Sep 16;13:972266. doi: 10.3389/fimmu.2022.972266. eCollection 2022.
Front Immunol. 2022.
PMID: 36189260
Free PMC article.
Item in Clipboard
Combination of a MIP3α-antigen fusion therapeutic DNA vaccine with treatments of IFNα and 5-Aza-2'Deoxycytidine enhances activated effector CD8+ T cells expressing CD11c in the B16F10 melanoma model.
Fessler K, Gordy JT, Sandhu AK, Hui Y, Kapoor AR, Ayeh SK, Karanika S, Karakousis PC, Markham RB.
Fessler K, et al.
Res Sq [Preprint]. 2023 Aug 14:rs.3.rs-3243336. doi: 10.21203/rs.3.rs-3243336/v1.
Res Sq. 2023.
PMID: 37645859
Free PMC article.
Preprint.
Item in Clipboard
Cite
Cite